VaccineSTATS: Vaccine Pipeline/IP review (CAT No: VAVS016)

Published by: VacZine Analytics

Published: Oct. 1, 2012


Table of Contents

Executive Summary
R&D pipeline overview: by phase
R&D pipeline overview: by market segment
R&D pipeline overview: by pathogen
Market segment analysis: existing and new vaccines
Market segment analysis: top five companies
Market segment analysis: Infant/adolescent
Market segment analysis: Insect borne/endemic diseases
Market segment analysis: Adult/elderly
Market segment analysis: Sexually transmitted diseases
Global initiatives: vaccines for developing/emerging markets
Latest company pipeline updates
Sanofi Pasteur
GSK Biologicals
Novartis Vaccines
Pfizer Vaccines
Methodology
About VacZine Analytics
Disclaimer

Abstract

This analysis of the VacZine Analytics online R&D pipeline database focuses primarily on pathogens for which no vaccines are currently available. The objectives are to 1) Identify active clinical and preclinical projects, categorized by major market segment (Infant/adolescent, Sexually transmitted diseases, Insect borne/endemic diseases and Adult/elderly), 2) Compare and contrast the vaccine pipelines of the main multinational vaccine companies (MNCs) including GSK Biologicals, Merck & Co, Novartis Vaccines, Sanofi Pasteur and Pfizer and 3) Assess which vaccine segments/pathogens have the highest R&D interest to identify where companies may compete and grow. The vaccine R&D pipeline database contains around 280 validated entries of active commercial vaccine programs covering over 100 companies. It can be used for competitive intelligence, business development and strategic planning activities.

Get full details about this report >>
 
Learn more about this product


Price and delivery options

Search Inside Report

US: 800.298.5699

Int'l: +1.240.747.3093


 

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 400,000 market research reports, company profiles and country profiles from over 720 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.